The below online CPD modules from the current edition of Australian Pharmacist are available free for PSA members.
September 2020 – Chronic disease management 1
Acute coronary syndrome (ACS) significantly contributes to the morbidity and mortality of ischaemic heart disease, which remains the leading cause of death in Australia. Acute coronary syndrome (ACS) refers to coronary ischaemia that presents with new or increasing symptoms. The focus of this article is on the management of ST-elevation myocardial infarction (STEMI), and non-ST-elevation myocardial infarction (NSTEMI) highlighting important differences and similarities in the management approaches.
September 2020 – Chronic disease management 2
Tinnitus is a common condition affecting1 in 10 Australians. There is currently no cure. Pharmacist can help identify causes, implement preventative and management strategies and ensure that referral to the general practitioner is made as required.
September 2020 – Chronic disease management 3
Anxiety disorders are common and under-recognised in the community. Left untreated, an anxiety disorder can impair a person’s capacity to perform everyday tasks and can negatively impact on their quality of life.
Pharmacists play a key role in helping to identify patients with symptoms of anxiety, supporting these patients to seek assessment, facilitating adherence with pharmacotherapy and supporting the utilisation of non-drug adjunctive therapies in the management of this chronic condition.
September 2020 – Chronic disease management 4
This article provides an overview of benign prostatic hypertrophy/hyperplasia (BPH) addressing pathophysiology, symptoms, diagnosis, management options and patient counselling.
PSA members can view articles and submit answers to assessment questions from Australian Pharmacist CPD from the previous 24 months by clicking the links below.